Our previous study observed a highly significant correlation between preclinical hypomethylation of one CpG site of ACTB and increased risk of stroke 14 .
← all excerpts
ACTB hypermethylation in blood is a potential biomarker as predictor to the risk of coronary heart disease.
1
—
—